NCT06037473View on ClinicalTrials.gov

The Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg

RecruitingOBSERVATIONAL
Enrollment

2,600

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

January 1, 2029

Study Completion Date

August 1, 2029

Conditions
Growth Hormone TreatmentGrowth Disorders
Interventions
DRUG

Polyethylene glycol recombinant human growth hormone injection

0.1-0.3mg/kg.w

Trial Locations (1)

010

RECRUITING

Department of Endocrinology, Genetics, Metabolism, Beijing

All Listed Sponsors
collaborator

University of Glasgow

OTHER

lead

Beijing Children's Hospital

OTHER